Trial Outcomes & Findings for Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses (NCT NCT00663819)
NCT ID: NCT00663819
Last Updated: 2018-04-17
Results Overview
The primary endpoint for the study is the proportion of subjects who experience a clinical and/or radiologic anastomotic leak through 4 - 12 weeks post procedure.
TERMINATED
NA
258 participants
Completion of procedure through 4-12 weeks post procedure
2018-04-17
Participant Flow
Participant milestones
| Measure |
Device
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
|
Procedure/Surgery
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement
Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
|
|---|---|---|
|
Overall Study
STARTED
|
123
|
135
|
|
Overall Study
COMPLETED
|
123
|
135
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Baseline characteristics by cohort
| Measure |
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement
n=123 Participants
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
|
Procedure/Surgery
n=135 Participants
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement
Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
|
Total
n=258 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
54.7 years
n=5 Participants
|
56.1 years
n=7 Participants
|
55.4 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
63 Participants
n=5 Participants
|
42 Participants
n=7 Participants
|
105 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
60 Participants
n=5 Participants
|
93 Participants
n=7 Participants
|
153 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
123 participants
n=5 Participants
|
135 participants
n=7 Participants
|
258 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Completion of procedure through 4-12 weeks post procedureThe primary endpoint for the study is the proportion of subjects who experience a clinical and/or radiologic anastomotic leak through 4 - 12 weeks post procedure.
Outcome measures
| Measure |
Device
n=123 Participants
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
|
Procedure/Surgery
n=135 Participants
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement
Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
|
|---|---|---|
|
Proportion of Subjects Who Experience a Clinical and/or Radiologic Anastomotic Leak
|
14 Participants
|
17 Participants
|
SECONDARY outcome
Timeframe: Post operativeOutcome measures
| Measure |
Device
n=123 Participants
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
|
Procedure/Surgery
n=135 Participants
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement
Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
|
|---|---|---|
|
Identify and Compare the Rate of Anastomotic Stenosis Associated With Circular Stapled Anastomoses Constructed With and Without CBSG.
|
1 Participants
|
11 Participants
|
SECONDARY outcome
Timeframe: Post operativeOutcome measures
| Measure |
Device
n=123 Participants
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
|
Procedure/Surgery
n=135 Participants
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement
Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
|
|---|---|---|
|
Determine the Rate of Significant Staple Line Hemorrhage With and Without the Use of CBSG in Circular Stapled Anastomoses
|
2 Participants
|
6 Participants
|
SECONDARY outcome
Timeframe: Within 4 - 12 weeks post-surgeryPopulation: "Significant" Post Operative Complications
Compare th number of patients experiencing significant post-operative complications when performing high-risk colorectal, coloanal, and Ileoanal anastomoses across both groups studied.
Outcome measures
| Measure |
Device
n=123 Participants
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
|
Procedure/Surgery
n=135 Participants
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement
Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
|
|---|---|---|
|
Determine the Efficacy and Further Substantiate Safety of CBSG Used in Conjunction With Circular Staplers When Performing High-risk Colorectal, Coloanal, and Ileoanal Anastomoses.
|
13 Participants
|
10 Participants
|
Adverse Events
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement
Procedure/Surgery
Serious adverse events
| Measure |
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement
n=123 participants at risk
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
|
Procedure/Surgery
n=135 participants at risk
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement
Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
|
|---|---|---|
|
Surgical and medical procedures
Anastomotic Leak, significant
|
10.6%
13/123 • Number of events 123 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
7.4%
10/135 • Number of events 135 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
|
Infections and infestations
Deep organ space infection
|
2.4%
3/123 • Number of events 3 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
3.7%
5/135 • Number of events 5 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
|
Infections and infestations
Peritonitis
|
1.6%
2/123 • Number of events 2 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
0.74%
1/135 • Number of events 1 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
|
Gastrointestinal disorders
Bowel obstruction
|
2.4%
3/123 • Number of events 3 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
8.9%
12/135 • Number of events 12 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
|
Gastrointestinal disorders
Prolonged ileus
|
14.6%
18/123 • Number of events 18 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
16.3%
22/135 • Number of events 22 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
Other adverse events
| Measure |
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement
n=123 participants at risk
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular staplers
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement: Colorectal, coloanal, and ileoanal anastomotic staple line reinforcement with GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement configured for circular stapler
|
Procedure/Surgery
n=135 participants at risk
Procedure/Surgery: colorectal, coloanal, and ileoanal anastomotic staple line without reinforcement
Staple line without reinforcement: colorectal and coloanal anastomotic staple line without reinforcement
|
|---|---|---|
|
Surgical and medical procedures
Anastomotic leak, non-significant
|
0.81%
1/123 • Number of events 1 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
5.2%
7/135 • Number of events 7 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
|
Infections and infestations
Superficial wound infection
|
8.9%
11/123 • Number of events 11 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
17.0%
23/135 • Number of events 23 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
|
Surgical and medical procedures
Anastomotic bleeding
|
1.6%
2/123 • Number of events 2 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
4.4%
6/135 • Number of events 6 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
|
General disorders
Fistula formation
|
0.81%
1/123 • Number of events 1 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
1.5%
2/135 • Number of events 2 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
|
Surgical and medical procedures
Stenosis (stricture)
|
0.81%
1/123 • Number of events 1 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
8.1%
11/135 • Number of events 11 • Post operative Day1, Day 3, prior to hospital discharge; at 4 - 12 weeks after surgery; at 90 days post surgery
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60